“…The tertiary amine, oxybutynin, has been shown to be an effective spasmo lytic in a number o f in vitro smooth muscle preparations, and to be o f clinical value in the treatment o f gastrointestinal and urinary tract hypermotility (4,6,8,9,11,13,15). In this laboratory oxybutynin has been shown to exert a moderate anticholinergic effect on rabbit detrusor in vitro, midway in potency between that o f the tertiary amine, atropine, and the smooth muscle relaxant, papaverine.…”
Oxybutynin chloride exerts a moderate anticholinergic effect on rabbit detrusor in vitro, which is reversible and competitive in nature (Kg = 4.7 × 10–9), and midway in potency between atropine and papaverine. In addition, oxybutynin strongly antagonizes BaCl2-induced spasms of detrusor with a potency equivalent to that of papaverine and 10 times that of atropine. This musculotropic spasmolytic effect is slightly greater in rabbit than human or monkey tissue, and noncompetitive (pD2 = 5.5). This direct relaxant effect, unlike that of papaverine, is not mediated by the inhibition of tissue phosphodiesterase, but probably reflects oxybutynin’s local anesthetic properties and associated effects on Ca++ fluxes and binding.
“…The tertiary amine, oxybutynin, has been shown to be an effective spasmo lytic in a number o f in vitro smooth muscle preparations, and to be o f clinical value in the treatment o f gastrointestinal and urinary tract hypermotility (4,6,8,9,11,13,15). In this laboratory oxybutynin has been shown to exert a moderate anticholinergic effect on rabbit detrusor in vitro, midway in potency between that o f the tertiary amine, atropine, and the smooth muscle relaxant, papaverine.…”
Oxybutynin chloride exerts a moderate anticholinergic effect on rabbit detrusor in vitro, which is reversible and competitive in nature (Kg = 4.7 × 10–9), and midway in potency between atropine and papaverine. In addition, oxybutynin strongly antagonizes BaCl2-induced spasms of detrusor with a potency equivalent to that of papaverine and 10 times that of atropine. This musculotropic spasmolytic effect is slightly greater in rabbit than human or monkey tissue, and noncompetitive (pD2 = 5.5). This direct relaxant effect, unlike that of papaverine, is not mediated by the inhibition of tissue phosphodiesterase, but probably reflects oxybutynin’s local anesthetic properties and associated effects on Ca++ fluxes and binding.
“…Gut stimulants such as carbachol and magnesium sulphate lead to an increased production of bowel sounds [ 46 ]. Furthermore, Martin et al [ 47 ] studied the effect of anti-spasmodic drugs, oxybutynin and dicyclomine on gastrointestinal activity using a microphone with a panasonic recorder embedded in a polystyrene cotton-padded box. A decrease in bowel sounds following drug administration was noted.…”
Section: Effect Of Modifiable and Non-modifiable Factors On Bowel Soundsmentioning
Production of bowel sounds, established in the 1900s, has limited application in existing patient-care regimes and diagnostic modalities. We review the physiology of bowel sound production, the developments in recording technologies and the clinical application in various scenarios, to understand the potential of a bowel sound recording and analysis device—the phonoenterogram in future gastroenterological practice. Bowel sound production depends on but is not entirely limited to the type of food consumed, amount of air ingested and the type of intestinal contractions. Recording technologies for extraction and analysis of these include the wavelet-based filtering, autoregressive moving average model, multivariate empirical mode decompression, radial basis function network, two-dimensional positional mapping, neural network model and acoustic biosensor technique. Prior studies evaluate the application of bowel sounds in conditions such as intestinal obstruction, acute appendicitis, large bowel disorders such as inflammatory bowel disease and bowel polyps, ascites, post-operative ileus, sepsis, irritable bowel syndrome, diabetes mellitus, neurodegenerative disorders such as Parkinson’s disease and neonatal conditions such as hypertrophic pyloric stenosis. Recording and analysis of bowel sounds using artificial intelligence is crucial for creating an accessible, inexpensive and safe device with a broad range of clinical applications. Microwave-based digital phonoenterography has huge potential for impacting GI practice and patient care.
“…It was found by Politzer et al 14 that, the contents of the intestine influence the frequency content of the sounds as well as the energy of the sounds. In addition, it was found that different regions of the abdominal tract are likely to produce sounds with different characteristic frequencies and amplitudes 15 . A study by Yoshino et al 16 concentrated specifically on the frequency of sounds detected at a single location on the abdominal wall.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.